Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome.
Celastrol and Its Role in Controlling Chronic Diseases.
[A young woman with central facial nerve palsy].
Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics.
Gender, ethnicity, and physician-patient communication about depression and anxiety in primary care.
Fatal herpes encephalitis in a patient with small cell lung cancer following prophylactic cranial radiation - a case report with review of literature.
GENETIC POLYMORPHISMS OF HUMAN β-DEFENSINS IN PATIENTS WITH MULTIPLE SCLEROSIS.
Role of Pulmonary Evaluation in Diagnosis of Neurosarcoidosis.
Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.
A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multiple Sclerosis.
Kainic Acid-Induced Excitotoxicity Experimental Model: Protective Merits of Natural Products and Plant Extracts.
Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland In 2013.
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.
Systematically developed pilot randomized controlled trial of exercise and cognition in persons with multiple sclerosis.
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
Genetics of rat neuroinflammation.
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Key players in neurodegenerative disorders in focus - new insights into the proteomic profile of Alzheimer`s disease, schizophrenia, ALS and multiple sclerosis - 24th HUPO BPP Workshop: 29 September 2015, Vancouver, Canada.
Inside front cover: Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China.
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
MAG, myelin and overcoming growth inhibition in the CNS.
The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.

Pages